Evidence map›Paper›PMID 29071444›Full record

ArticleEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2018

Multivariate analysis of prognostic factors for idiopathic sudden sensorineural hearing loss treated with adjuvant hyperbaric oxygen therapy.

Shaobing Xie, Qingfen Qiang, Lingyun Mei, Chufeng He, Yong Feng, Hong Sun, Xuewen Wu

Abstract read
PubMed Publisher
In one paragraph

Article in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 47 citations in OpenAlex.

  1. [The efficacy of hyperbaric oxygen in the treatment of sudden sensorineural hearing loss].Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2020
    Trial
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Better late than never: initial experience of intra-arterial pulsed-urokinase-injection as a salvage therapy for refractory sudden sensorineural hearing loss.Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2022
    Article
  8. Article
  9. Investigation of the prognostic role of neutrophil-to-lymphocyte ratio in Idiopathic Sudden Sensorineural Hearing Loss based on propensity score matching: a retrospective observational study.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2020
    Observational
  10. Review
  11. Article
  12. The use of hyperbaric oxygen therapy in acute hearing loss: a narrative review.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2019
    Review
  13. Prediction of hearing recovery in sudden deafness treated with intratympanic steroids.Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale · 2018
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Shaobing XieDepartment of Otolaryngology Head and Neck Surgery, Xiangya Hospital Central South University, Changsha, 410008, Hunan, China.
Qingfen QiangDepartment of Otolaryngology Head and Neck Surgery, Xiangya Hospital Central South University, Changsha, 410008, Hunan, China.
Lingyun MeiDepartment of Otolaryngology Head and Neck Surgery, Xiangya Hospital Central South University, Changsha, 410008, Hunan, China.
Chufeng HeDepartment of Otolaryngology Head and Neck Surgery, Xiangya Hospital Central South University, Changsha, 410008, Hunan, China.
Yong FengDepartment of Otolaryngology Head and Neck Surgery, Xiangya Hospital Central South University, Changsha, 410008, Hunan, China.
Hong SunDepartment of Otolaryngology Head and Neck Surgery, Xiangya Hospital Central South University, Changsha, 410008, Hunan, China.
Xuewen WuDepartment of Otolaryngology Head and Neck Surgery, Xiangya Hospital Central South University, Changsha, 410008, Hunan, China. xwwu840903@hotmail.com.ORCID http://orcid.org/0000-0001-7271-7965
Central South University · CN

Funding

National Key Basic Research Program of China 2014CB943003National Natural Science Foundation of China 81170912National Natural Science Foundation of China 81300819
6 · The paper itself

Abstract

The objective of this study is to evaluate possible prognostic factors of idiopathic sudden sensorineural hearing loss (ISSNHL) treated with adjuvant hyperbaric oxygen therapy (HBOT) using univariate and multivariate analyses. From January 2008 to October 2016, records of 178 ISSNHL patients treated with auxiliary hyperbaric oxygen therapy were reviewed to assess hearing recovery and evaluate associated prognostic factors (gender, age, localization, initial hearing threshold, presence of tinnitus, vertigo, ear fullness, hypertension, diabetes, onset of HBOT, number of HBOT, and audiogram), by using univariate and multivariate analyses. The overall recovery rate was 37.1%, including complete recovery (19.7%) and partial recovery (17.4%). According to multivariate analysis, later onset of HBOT and higher initial hearing threshold were associated with a poor prognosis in ISSNHL patients treated with HBOT. HBOT is a safe and beneficial adjuvant therapy for ISSNHL patients. 20 sessions of HBOT is possibly enough to show its therapeutic effect. Earlier HBOT onset and lower initial hearing threshold is associated with favorable hearing recovery.

Indexed as

Hyperbaric OxygenationAdolescentAdultAgedChildCombined Modality TherapyFemaleFollow-Up StudiesHearing Loss, SensorineuralHearing Loss, SuddenHumansMaleMiddle AgedMultivariate AnalysisPrognosisRetrospective StudiesHyperbaric oxygen therapyIdiopathic sudden sensorineural hearing lossMultivariate analysis.Prognostic factors

Identifiers

PMID29071444
OpenAlexW2765120611

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.